Estimates Revisions Omnicell, Inc. Deutsche Boerse AG
Stocks
OC9
US68213N1090
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.70 EUR | +5.30% |
|
+3.61% | +3.61% |
| 07-01 | Omnicell, Inc. Announces Executive Changes | CI |
| 07-01 | Omnicell Names Nnamdi Njoku as President | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| - | - | ||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
- Stock Market
- Stocks
- OMCL Stock
- OC9 Stock
- Consensus Omnicell, Inc.
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
